OKYO Pharma Ltd (OKYO) stock
OKYONasdaqBiological Products, (No Diagnostic Substances)
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Mar 31, 2026Last filing: 20-F on Jul 20, 2026Score 1/30
$1.16+0.06 (+5.45%)
Close on Nov 19, 2026Market cap $60.88MP/E –Yield –
OKYO Pharma total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
OKYO Pharma's total debt was $2.70M at Mar 31, 2025. For fiscal 2025 it was $2.70M.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $2.70M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $2.70M | – |
See a number that looks wrong?